About 300 reports

  • Partnership agreements...

Clinical initiatives in genetic space for management of HCM MUTATION Source: Technavio Genetic testing The advances in the genetic diagnosis of HCM has helped in categorizing the individuals with HCM into two groups.

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • PERSONALIZED MEDICINE FOR TREATMENT OF CARDIOVASCULAR DISORDERS
  • SANOFI

Sanofi' s growth strategy aims at innovating better cure for genetic cardiovascular diseases.

  • Cardiovascular Disease
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • presents estimates of the global prevalence of diabetes.
  • presents major genes associated with an increased risk of diabetes.

These ## disorders represent many of the most prevalent genetic disorders which are targets for molecular genetic testing.

  • Cardiovascular Disease
  • World
  • Cepheid
  • Hologic, Inc.
  • Roche Group
  • PATHOPHYSIOLOGY OF HYPERTENSION

Manufactures biotechnology and genetic products.

  • Cardiovascular Disease
  • Actelion Ltd
  • AstraZeneca PLC
  • Daiichi Sankyo Company
  • Sanofi S.A.

Genetic characteristics are common to many Japanese which also contribute to the higher prevalence of diabetes.

  • Cardiovascular Disease
  • World
  • Market Size
  • Collagen Solutions plc
  • Jellagen Pty Ltd

Istaroxime (CVie Therapeutics) PB-## (PhaseBio Pharmaceuticals) omecamtiv mecarbil (Cytokinetics & Amgen) CXL-## (Bristol Myers Squibb) Research Findings Kidney Dysfunction - Predictor of Acute Heart failure Genetic Influence on Heart Disease among African Americans Higher Body Mass

  • Cardiovascular Disease
  • Heart Failure
  • Europe
  • United States
  • World
  • ATRIAL FIBRILLATION ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
  • VENTRICULAR TACHYCARDIA PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)

Increasing lifestyle disorders such as obesity, high blood pressure, sleep disorders; genetic disorders and hormonal changes are causing increased prevalence of varicose vein.

  • Cardiovascular Disease
  • World
  • Market Size
  • Boston Scientific Corporation
  • CONMED Corporation
  • Aetiologies of Heart Failure

Clinical status DISEASE PROGNOSIS & CLINICAL COURSE VARIATION BY GEOGRAPHY/ ETHNICITY ITEM Myocardial remodelling and severity of heart dysfunction Biomarkers of neurohormonal activation Other biomarkers Genetic testing Cardiovascular co-morbidities Non-cardiovascular co-morbidities

  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • Pathology
  • Europe

Most are the result of a genetic alteration, although infection, trauma, or atherosclerosis can cause aneurysms.

  • Cardiovascular Disease
  • Covidien plc
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • MicroVention, Inc.

Most are the result of a genetic alteration, although infection, trauma, or atherosclerosis can cause aneurysms.

  • Cardiovascular Disease
  • Covidien plc
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • MicroVention, Inc.
  • 2.3.4 STRESS TESTING
  • 2.4.1 HYPERTENSION

Stroke is related to various genetic mutations, such as mutations in the CYP##A## and PROC genes.

  • Cardiovascular Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MARKET SIZE AND FORECAST
  • Global blood pressure monitoring testing market 2015-2020 ($ billions)

Other risks include genetic predisposition and preexisting health conditions like CKDs, thyroid problems, diabetes, sleep apnea, tumors, and medications and supplements.

  • Blood Device
  • Cardiovascular Disease
  • World
  • Omron Corporation
  • Welch Allyn Inc.

Genomics involves the study of genomes, the complete set of genetic material within any organism.

  • Beta-Blocker
  • Cardiovascular Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • SUPPORTIVE GOVERNMENT AND NON-GOVERNMENT INITIATIVES

For instance, the AHA along with Verily and AstraZeneca has invested around $## million on a research project called " One Brave Idea, " to understand the genetic and molecular factors in order to prevent coronary heart disease aiming to reduce cardiovascular mortality up to ##% by

  • Cardiovascular Disease
  • United States
  • Forecast
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • 2.1 Overview of Anticoagulants

Heart Attack Stroke Deep Venous Thrombosis (DVT) Pulmonary Embolism Atrial Fibrillation Artificial Heart Valve Prevention of blood clots e. g. genetic clotting disorders ##. ##. ## TYPES OF ANTICOAGULANTS ##. ## Overview of Anticoagulants Figure ## : Types of Anticoagulants Anticoagulants Typesof Hep

  • Cardiovascular Disease
  • World
  • Market Size
  • Bayer AG
  • Daiichi Sankyo Company
  • 3.2 RISK FACTORS AND COMORBIDITIES

It is now commonly believed that the development of PAH depends on individual susceptibility or predisposition, which is genetically determined.

  • Cardiovascular Disease
  • France
  • Germany
  • Japan
  • Forecast
  • Disease overview

Source: Technavio RISK FACTORS RISK FACTORS OF MYOCARDIAL INFARCTION Modifiable risk factors Hypercholesterolemia Hypertension Diabetes Obesity Sedentary lifestyle Smoking Depression and stress Age Gender Genetic and hereditary factors Non-modifiable risk factors Diagnosis of myocardial inf

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Novartis AG
  • NSTEMI group
  • Pfizer Inc.
  • 8.2.4 CER-001

CER-## WAS FURTHER EVALUATED IN TWO PHASE IIA TRIALS FOR RARE GENETIC CONDITIONS ASSOCIATED WITH ATHEROSCLEROSIS.

  • Cardiovascular Disease
  • World
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • MARKET OUTLINE

Excessive smoking, hypertension, weakness of the artery, and various other genetic factors contribute toward the aneurysm.

  • Cardiovascular Disease
  • Cook Medical, Inc.
  • Lombard Medical Technologies PLC
  • Medtronic, Inc.
  • Terumo Corporation
  • HOSPITALS

HOSPITALS IN EMEA UK Saudi Arabia Genetic problems and structural heart defects are one of the common problems encountered in the country.

  • Cardiology
  • Cardiovascular Disease
  • Electrophysiology Device
  • World
  • Biosense Webster, Inc.

GENCARO IS A BETA-BLOCKER AND MILD VASODILATOR AND IS BEING EVALUATED IN A PHASE IIB STUDY, THE GENETIC-AF TRIAL, IN A GENETICALLY MODIFIED HEART FAILURE POPULATION, WHICH INCLUDES HEART FAILURE PATIENTS WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION (HFREF).

  • Cardiovascular Disease
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company
  • Pfizer Inc.
  • CARDIOVASCULAR DISEASE THERAPEUTICS MARKET, GLOBAL, REVENUE FORECAST FOR BETRIXABAN
  • 2.3 ETIOLOGY, PATHOPHYSIOLOGY, COMORBIDITIES AND COMPLICATIONS

Individuals with genetic mutations that result in lower CETP levels have increased HDL levels.

  • Cardiovascular Disease
  • World
  • Market Size
  • Novartis AG
  • Sanofi S.A.
  • History of Stroke or Heart Attack
  • Risk Factors of Pulmonary Embolism

For instance, obesity is connected to genetic mutations F## G##A (Factor V Leiden) and F## G##A (prothrombin).

  • Blood Disease
  • Cardiovascular Disease
  • World
  • Cyclopharm Limited
  • Lifesciences Limited
  • SUPPORTIVE GOVERNMENT AND NON-GOVERNMENT INITIATIVES

For instance, the AHA along with Verily and AstraZeneca has invested around $## million on a research project called One Brave Idea, to understand the genetic and molecular factors in order to prevent coronary heart disease aiming to reduce cardiovascular mortality up to ##% by 2020.

  • Cardiovascular Disease
  • Forecast
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • HISTORY OF HYPERCHOLESTEROLEMIA

This genetic modulation, among other effects, leads to serum triglyceride lowering, which is the primary action of fibrates.

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 4.5.1 Etiology
  • 4.3.4 Stress Testing

The genetic landscape of Alzheimer disease: clinical implications and perspectives.

  • Cardiovascular Disease
  • World
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Systemic hypertension
  • 5.3 GLOBAL AND HISTORICAL TRENDS

It is now commonly believed that the development of PAH depends on individual susceptibility or predisposition, which is genetically determined.

  • Cardiovascular Disease
  • Forecast
  • Actelion Ltd
  • GlobalData's company
  • United Therapeutics Corporation

In 2011, the company acquired all the outstanding stock of a US-based provider of genetic biotechnology platforms, Revivicor.

  • Cardiovascular Disease
  • Actelion Ltd
  • Bayer AG
  • GlaxoSmithKline plc
  • United Therapeutics Corporation

Global ECG Market

3864 4250 3284

This high proportion of genetic cardiomyopathy is also expected to support the use of ECG screening.

  • Cardiovascular Disease
  • World
  • Cardiac Science Corporation
  • GE Healthcare Limited
  • Welch Allyn Inc.
  • Market size and forecast

Moreover, a rise in the incidence of genetic comorbidities is one of the factors responsible for the increase in the incidence of diseases that require thoracic surgery.

  • Cardiovascular Disease
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Sorin S.p.A.